Ramona Doyle

Insider Reports History

Entity
Individual
Location
C/O Recursion Pharmaceuticals, 41 S. Rio Grande Street, Salt Lake City, UT
Signature
/s/ Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ramona Doyle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Medical Officer Class A Common Stock 121K $1.28M $10.58 May 16, 2022 Direct
RECURSION PHARMACEUTICALS, INC. Chief Medical Officer Stock Option (Right to Buy) 669K Mar 31, 2022 Direct

Insider Reports Filed by Ramona Doyle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. May 16, 2022 1 -$4.72K 4 May 18, 2022 Chief Medical Officer
RXRX RECURSION PHARMACEUTICALS, INC. Mar 31, 2022 2 $22.5K 4 Apr 4, 2022 Chief Medical Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 28, 2022 2 $38.8K 4 Mar 1, 2022 Chief Medical Officer
RXRX RECURSION PHARMACEUTICALS, INC. Feb 4, 2022 5 -$11.2K 4 Feb 8, 2022 Chief Medical Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jan 31, 2022 2 $38.8K 4 Feb 2, 2022 Chief Medical Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jan 3, 2022 2 $99.6K 4 Jan 5, 2022 Chief Medical Officer